(0.12%) 5 220.32 points
(0.34%) 39 520 points
(-0.09%) 16 331 points
(0.23%) $79.44
(-0.39%) $2.29
(1.29%) $2 370.50
(0.35%) $28.47
(1.16%) $1 002.30
(0.18%) $0.929
(-0.14%) $10.85
(0.10%) $0.799
(-0.12%) $92.44
@ $14.28
Issued: 14 Feb 2024 @ 12:06
Return: -31.09%
Previous signal: Feb 13 - 14:46
Previous signal:
Return: -0.35 %
Live Chart Being Loaded With Signals
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States...
Stats | |
---|---|
Today's Volume | 71 514.00 |
Average Volume | 1.02M |
Market Cap | 540.34M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.360 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.07 |
ATR14 | $0.0670 (0.68%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Agarwal Sunil | Buy | 28 200 | Stock Option (Right to Buy) |
2024-04-05 | Agarwal Sunil | Buy | 0 | |
2024-04-01 | Morabito Christopher | Sell | 10 000 | Stock Option (Right to Buy) |
2024-04-01 | Morabito Christopher | Buy | 10 000 | Common Stock |
2024-04-01 | Morabito Christopher | Sell | 10 000 | Common Stock |
INSIDER POWER |
---|
96.96 |
Last 97 transactions |
Buy: 15 860 733 | Sell: 474 752 |
Volume Correlation
Astria Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Astria Therapeutics, Inc. Correlation - Currency/Commodity
Astria Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.42 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.42 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-3.43 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-49.16 |
Financial Reports:
No articles found.
Astria Therapeutics, Inc.
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators